WRN mutation
|
Small Cell Lung Cancer
|
WRN mutation
|
Small Cell Lung Cancer
|
olaparib Sensitive: C2 – Inclusion Criteria
|
olaparib Sensitive: C2 – Inclusion Criteria
|
WRN mutation
|
Prostate Cancer
|
WRN mutation
|
Prostate Cancer
|
olaparib Sensitive: C3 – Early Trials
|
olaparib Sensitive: C3 – Early Trials
|